Ahmet Afşin Oktay1, Halis Kaan Akturk, Eiman Jahangir. 1. aJohn Ochsner Heart and Vascular Institute, Ochsner Clinical School - The University of Queensland School of Medicine, New Orleans, Louisiana bDivision of Endocrinology, Mayo Clinic Florida, Jacksonville, Florida, USA.
Abstract
PURPOSE OF REVIEW: The following is a review of the current concepts on the relationship between hypertension (HTN) and diabetes mellitus with a focus on the epidemiology and cardiovascular prognostic implications of coexistent HTN and diabetes mellitus, shared mechanisms underlying both conditions and pathophysiology of increased risk of cardiovascular disease, treatment of HTN in individuals with diabetes mellitus, and effects of anti-diabetic medications on blood pressure (BP). RECENT FINDINGS: Diabetes mellitus and HTN often coexist in the same individual. They share numerous risk factors and underlying pathophysiologic mechanisms, most important of which are insulin resistance and inappropriate activation of the rennin-angiotensin-aldosterone system. Recently updated guidelines recommend a BP goal of 140/90 mmHg in most individuals with diabetes mellitus. A new class of anti-diabetic medications, sodium-glucose co-transporter 2 inhibitors, has shown favorable effects on BP. SUMMARY: HTN affects the majority of individuals with diabetes mellitus. Coexistence of diabetes mellitus and HTN, especially if BP is not well controlled, dramatically increases the risk of morbidity and mortality from cardiovascular disease. BP control is an essential part of management of patients with diabetes mellitus, because it is one of the most effective ways to prevent vascular complications and death.
PURPOSE OF REVIEW: The following is a review of the current concepts on the relationship between hypertension (HTN) and diabetes mellitus with a focus on the epidemiology and cardiovascular prognostic implications of coexistent HTN and diabetes mellitus, shared mechanisms underlying both conditions and pathophysiology of increased risk of cardiovascular disease, treatment of HTN in individuals with diabetes mellitus, and effects of anti-diabetic medications on blood pressure (BP). RECENT FINDINGS:Diabetes mellitus and HTN often coexist in the same individual. They share numerous risk factors and underlying pathophysiologic mechanisms, most important of which are insulin resistance and inappropriate activation of the rennin-angiotensin-aldosterone system. Recently updated guidelines recommend a BP goal of 140/90 mmHg in most individuals with diabetes mellitus. A new class of anti-diabetic medications, sodium-glucose co-transporter 2 inhibitors, has shown favorable effects on BP. SUMMARY: HTN affects the majority of individuals with diabetes mellitus. Coexistence of diabetes mellitus and HTN, especially if BP is not well controlled, dramatically increases the risk of morbidity and mortality from cardiovascular disease. BP control is an essential part of management of patients with diabetes mellitus, because it is one of the most effective ways to prevent vascular complications and death.
Authors: Rachael C Aikens; Wei Zhao; Danish Saleheen; Muredach P Reilly; Stephen E Epstein; Emmi Tikkanen; Veikko Salomaa; Benjamin F Voight Journal: Diabetes Date: 2016-10-04 Impact factor: 9.461
Authors: Kaumudi J Joshipura; Francisco J Muñoz-Torres; Maribel Campos; Alba D Rivera-Díaz; Juan C Zevallos Journal: J Hum Hypertens Date: 2017-11-07 Impact factor: 3.012
Authors: Tran Quoc Cuong; Le Van Bao; Nguyen Anh Tuan; Vo Van Thang; Nguyen Minh Quan; Shwu-Huey Yang; Tuyen Van Duong Journal: Int J Environ Res Public Health Date: 2019-11-26 Impact factor: 3.390
Authors: Jie Li; Haiyan Shangguan; Xiaoqian Chen; Xiao Ye; Bin Zhong; Pen Chen; Yamei Wang; Bin Xin; Yan Bi; Dalong Zhu Journal: Open Life Sci Date: 2020-06-11 Impact factor: 0.938